Hydroxychloroquine Screening Guidelines: Best Evidence, Controversies, and Future Areas of Research
- PMID: 38146891
- DOI: 10.1097/IIO.0000000000000508
Hydroxychloroquine Screening Guidelines: Best Evidence, Controversies, and Future Areas of Research
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
References
-
- Akhavan PS, Su J, Lou W, et al. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol. 2013;40:831–841.
-
- Alarcón GS, McGwin G, Bertoli AM, et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168–1172.
-
- Pons-Estel GJ, Alarcón GS, McGwin G, et al. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Care Res. 2009;61:830–839.
-
- Tang C, Godfrey T, Stawell R, et al. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Intern Med J. 2012;42:968–978.
-
- Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16:155–166.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
